Us Bancorp \De\ Horizon Therapeutics Public LTD CO Transaction History

Us Bancorp \De\

$71.8 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$98.98 - $115.74 $46,421 - $54,282	-469 Reduced 2.89%	15,785 $1.83 Million
Q2 2023 Aug 09, 2023	SELL	$96.34 - $112.38 $256,649 - $299,380	-2,664 Reduced 14.08%	16,254 $1.67 Million
Q1 2023 May 09, 2023	SELL	$107.32 - $113.5 $2.83 Million - $3 Million	-26,391 Reduced 58.25%	18,918 $2.06 Million
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $13,725 - $25,036	220 Added 0.49%	45,309 $5.16 Million
Q3 2022 Oct 27, 2022	BUY	$58.92 - $84.67 $160,851 - $231,149	2,730 Added 6.44%	45,089 $2.79 Million

Q2 2022 Aug 01, 2022	SELL	$79.4 - $116.36 $158,800 - $232,720	-2,000 Reduced 4.51%	42,359 $3.38 Million
Q1 2022 May 11, 2022	BUY	$86.42 - $109.81 $15,469 - $19,655	179 Added 0.41%	44,359 $4.67 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $46,027 - $55,997	-467 Reduced 1.05%	44,180 $4.76 Million
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $65,991 - $79,245	-718 Reduced 1.58%	44,647 $4.89 Million
Q2 2021 Aug 05, 2021	SELL	$86.24 - $95.92 $1,724 - $1,918	-20 Reduced 0.04%	45,365 $4.25 Million
Q1 2021 Apr 28, 2021	BUY	$71.83 - $95.48 $124,409 - $165,371	1,732 Added 3.97%	45,385 $4.18 Million
Q4 2020 Feb 04, 2021	SELL	$67.0 - $84.39 $24,053 - $30,296	-359 Reduced 0.82%	43,653 $3.19 Million
Q3 2020 Nov 10, 2020	SELL	$55.23 - $79.93 $336,792 - $487,413	-6,098 Reduced 12.17%	44,012 $3.42 Million
Q2 2020 Aug 07, 2020	BUY	$30.2 - $56.98 $404,589 - $763,361	13,397 Added 36.49%	50,110 $2.79 Million
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $54,639 - $84,716	-2,197 Reduced 5.65%	36,713 $1.09 Million
Q4 2019 Feb 04, 2020	SELL	$25.43 - $36.67 $106,806 - $154,014	-4,200 Reduced 9.74%	38,910 $1.41 Million
Q3 2019 Nov 08, 2019	SELL	$23.0 - $27.97 $315,606 - $383,804	-13,722 Reduced 24.14%	43,110 $1.17 Million
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $1.3 Million - $1.62 Million	56,832 New	56,832 $1.37 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account